Cargando…

Breast Cancer Screening in High-Risk Women

Detalles Bibliográficos
Autores principales:	Brekelmans, C. T. M., Bartels, C. C. M., Crepin, E., van Geel, A. N., Meijers-Heijboer, H., Seynaeve, C., Tilanus-Linthorst, M. M. A., Verhoog, L. C., Wagner, A., Klijn, J. G. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 1999
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851971/ https://www.ncbi.nlm.nih.gov/pubmed/10595248 http://dx.doi.org/10.1155/1999/160437

Ejemplares similares

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
por: Verhoog, L C, et al.
Publicado: (2000)

Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2007)

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy
por: Tan, Murly BM, et al.
Publicado: (2009)

Impact of screening for breast cancer in high-risk women on health-related quality of life
por: Rijnsburger, A J, et al.
Publicado: (2004)

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk
por: Geuzinge, H. Amarens, et al.
Publicado: (2021)

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
por: Saadatmand, Sepideh, et al.
Publicado: (2012)

Author Reply: Decision-Making Management of Women with a High Risk of Developing Breast and Ovarian Cancer
por: Heemskerk-Gerritsen, Bernadette, et al.
Publicado: (2008)

A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer
por: Smith, J, et al.
Publicado: (2009)

Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer families
por: Peelen, T, et al.
Publicado: (2000)

Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features
por: Berns, E M J J, et al.
Publicado: (2001)

Breast Cancer Screening in Perimenopausal Women
por: Anand, Nupur, et al.
Publicado: (2022)

The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer
por: Beral, Valerie, et al.
Publicado: (2011)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016)

Implementation of long-term non-participant reminders for flexible sigmoidoscopy screening
por: Kerrison, R.S., et al.
Publicado: (2021)

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients
por: Saadatmand, Sepideh, et al.
Publicado: (2015)

The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
por: Mead, L, et al.
Publicado: (2015)

Comment on Screening by MRI Mentioned in the Reviews by Narod and Møller
por: Kriege, Mieke, et al.
Publicado: (2004)

Characteristics associated with healthcare disruptions during the COVID-19 pandemic for women in the United States at high risk for breast cancer
por: Conley, Claire C., et al.
Publicado: (2022)

High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening
por: Greenfield, D M, et al.
Publicado: (2006)

Age-specific risk of breast cancer in women with neurofibromatosis type 1
por: Seminog, O O, et al.
Publicado: (2015)

Sleep duration and breast cancer risk in the Breast Cancer Detection Demonstration Project follow-up cohort
por: Qian, X, et al.
Publicado: (2015)

Trust and cancer screening: Effects of a screening controversy on women’s perceptions of cervical cancer screening
por: O'Donovan, B., et al.
Publicado: (2021)

The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2004)

Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients
por: Tadler, M, et al.
Publicado: (2014)

Skin cancer screening participation and impact on melanoma incidence in Germany – an observational study on incidence trends in regions with and without population-based screening
por: Waldmann, A, et al.
Publicado: (2012)

Acute effects of resistance exercise and intermittent intense aerobic exercise on blood cell count and oxidative stress in trained middle-aged women
por: Cardoso, A.M., et al.
Publicado: (2012)

A polymorphism in the CYP17 gene is associated with male breast cancer
por: Young, I E, et al.
Publicado: (1999)

Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences
por: Chen, Y-Y, et al.
Publicado: (2009)

Birth weight and breast cancer risk
por: Troisi, R, et al.
Publicado: (2006)

Breast cancer survival and prognosis by screening history
por: Coldman, A J, et al.
Publicado: (2014)

Risks of second primary cancer among patients with major histological types of lung cancers in both men and women
por: Chuang, S-C, et al.
Publicado: (2010)

Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Ahn, J, et al.
Publicado: (2009)

Pain pressure threshold algometry of the abdominal wall in healthy women
por: Montenegro, M.L.L.S., et al.
Publicado: (2012)

Left-handedness and risk of breast cancer
por: Fritschi, L, et al.
Publicado: (2007)

Perceived life expectancy and colorectal cancer screening intentions and behaviour: A population-based UK study
por: Dodd, Rachael H., et al.
Publicado: (2019)

The Role of Bilateral Prophylactic Mastectomy (BPMX) in Women at High Risk of Breast Cancer
por: Baildam, A. D.
Publicado: (1999)

Feasibility of maintaining near-normal glucose control in pregnant women with type 1 diabetes during COVID-19 lockdown
por: Mateu-Salat, M., et al.
Publicado: (2022)

Getting the timing right: Women’s views on the best time to announce changes to cancer screening policy recommendations
por: Dodd, Rachael H., et al.
Publicado: (2020)

Fewer invited talks by women in evolutionary biology symposia
por: Schroeder, J, et al.
Publicado: (2013)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
por: Bulk, S, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ltudepda4790iq6tut8ild2u77